Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eyenovia Inc.

1.09
-0.0400-3.54%
Post-market: 1.090.00000.00%18:27 EDT
Volume:25.63K
Turnover:28.01K
Market Cap:3.09M
PE:-0.02
High:1.16
Open:1.14
Low:1.05
Close:1.13
Loading ...

Eyenovia Inc expected to post a loss of $7.20 a share - Earnings Preview

Reuters
·
16 Apr

Eyenovia Inc expected to post a loss of $7.20 a share - Earnings Preview

Reuters
·
12 Apr

Eyenovia Inc expected to post a loss of $7.20 a share - Earnings Preview

Reuters
·
09 Apr

Eyenovia Inc expected to post a loss of $7.20 a share - Earnings Preview

Reuters
·
05 Apr

Eyenovia Inc expected to post a loss of $7.20 a share - Earnings Preview

Reuters
·
02 Apr

BRIEF-Eyenovia Files For Non-Timely 10-K - SEC Filing

Reuters
·
01 Apr

Eyenovia Files for Non-Timely 10-K - SEC Filing

THOMSON REUTERS
·
01 Apr

Eyenovia: Sees Significant Non-Cash Impairment for FY Ended Dec 2024 on Strategic Alternatives Uncertainty - SEC Filing

THOMSON REUTERS
·
01 Apr

Eyenovia Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Mar

BUZZ-U.S. STOCKS ON THE MOVE-KKR, Micron Technology, Eli Lilly

Reuters
·
20 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Five Below, QXO, PDD Holdings

Reuters
·
20 Mar

Eyenovia Shares Down 15.6% After Co to Effect Reverse Merger With Betaliq

THOMSON REUTERS
·
20 Mar

BUZZ-Eyenovia falls after plans to merge with private firm Betaliq

Reuters
·
20 Mar

Eyenovia Shares Rise 5.4% Premarket After Co to Effect Reverse Merger With Betaliq

THOMSON REUTERS
·
20 Mar

Eyenovia Plans All-Stock Reverse Merger With Betaliq

Dow Jones
·
20 Mar

BRIEF-Eyenovia Enters Into Non-Binding Letter Of Intent To Effect Reverse Merger With Betaliq

Reuters
·
20 Mar

Eyenovia Enters Into Non-Binding Letter of Intent to Effect Reverse Merger With Betaliq

THOMSON REUTERS
·
20 Mar

Eyenovia Inc - Proposed Transaction Values Betaliq at $77 Million, Eyenovia at $15 Million

THOMSON REUTERS
·
20 Mar

Eyenovia Inc - Betaliq Equity Holders to Own 83.7% of Combined Company, Eyenovia 16.3%

THOMSON REUTERS
·
20 Mar

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

GlobeNewswire
·
20 Mar